Anita Bellail
![Anita Bellail Anita Bellail](https://proteindegradation.com/wp-content/uploads/sites/82/2024/06/Anita-Bellail-150x150.png)
Company: HB Therapeutics
Job title: CSO and COO
Seminars:
Discovery & Development of Small-Molecule Glue Degraders of KRAS G12D as the First-in-Class Anticancer Drugs 2:00 pm
Cancer cell-based drug screening identified hit compounds that abide Lipinski rule and degrade active GTP KRAS G12D protein in KRAS G12D mutated cancer cells High-throughput technologies revealed a novel E3 ligase and mechanism of drug action in which degraders bind the E3 ligase and KRAS G12D and induce the KRAS degradation Protein structure-guided and AI-powered…Read more
day: Bootcamp Day